He also takes albuterol, also from AstraZeneca, for his asthma. Despite having health insurance, Shapland said the cost can ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ...

AstraZeneca, Boehringer Ingelheim, and GSK—have announced plans to cap the monthly cost of their inhaler products at $35.

The program automatically reduces the cost of the inhaler at the pharmacy for eligible patients with commercial insurance. Out-of-pocket costs for Boehringer Ingelheim asthma and chronic obstructive ...

Kylee Marie Reiber knew something was wrong. The McCandless sixth-grader had struggled to manage asthma her whole life, ...

Previous guidelines recommended the use of maintenance inhalers such as those that combine ICS and a long-acting beta agonist ...

Brand-name drug costs continue to climb, but patients and insurers find respite by migrating to generic or biosimilar ...

Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now available. With this program, patients who have had difficulty ...

There are two types of prescription asthma medicines: quick-relief and long-term control.

The new inhalers combine inflammation-fighting corticosteroids with a long-acting drug called formoterol that opens up the ...

Little League baseball players wheeze as they cross home plate and try to catch their breath. Players, coaches, umpires and ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / June 3, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will ...